基于NHANES 2013-2016的心血管--代谢综合征的全环境关联研究
Jianhua Ma1, Pingan Li1, Lixin Tao1
1School of Public Health, Capital Medical University, No.10 Xitoutiao, Youanmen Street, Beijing 100069, China; Beijing Key Laboratory of Environment and Aging, Capital Medical University, Beijing 100069, China.
Ecotoxicology and environmental safety
|September 3, 2025
概括
环境化学物质暴露与心血管--代谢综合征 (CKM) 有关. 炎症可能是这种关联的媒介,强调需要控制化学物质暴露以预防慢性疾病.
科学领域:
- 环境健康
- 毒理学
- 公共卫生
背景情况:
- 环境中的化学物质暴露是慢性疾病的重要危险因素.
- 心血管--代谢综合症 (CKM) 综合了心血管,和代谢疾病.
- 鉴定CKM综合征的环境风险因素对于公共健康至关重要.
研究的目的:
- 评估多种环境化学物质与CKM综合征之间的关联.
- 研究炎症在这些关联中的调解作用.
- 采用全暴露体的方法来全面识别风险因素.
主要方法:
- 使用NHANES数据 (2013-2016) 采用全暴露组方法.
- 用于非线性关联分析的限制立方线 (RCS).
- 应用于加权量子总和 (WQS) 回归和基于量子的g计算 (Qgcomp) 进行联合暴露分析.
- 进行调解分析以探索炎症的作用.
主要成果:
- 与CKM综合征相关的六种化学物质 (金属,VOCM,PAH,).
- 观察到,,,酸盐和2&3-烯的U形关系.
- 结合金属暴露增加了CKM综合征的风险;炎症可能是介导因素.
结论:
- 控制环境化学物质暴露对于预防慢性多系统性疾病至关重要.
- 这些发现为CKM综合征背后的生物机制提供了新的视角.
- 强调需要采用综合方法来预防和管理CKM综合征.
更多相关视频
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Assessment of the Cardiovascular System I: Subjective Data
467
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
467
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332


